Gilder Gagnon Howe & Co’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.48M | Buy |
|
|||||
|
2025
Q1 | $612K | Sell |
|
|||||
|
2024
Q4 | $712K | Sell |
|
|||||
|
2024
Q3 | $1.09M | Sell |
|
|||||
|
2024
Q2 | $819K | Buy |
|
|||||
|
2024
Q1 | $813K | Sell |
|
|||||
|
2023
Q4 | $842K | Buy |
|
|||||
|
2023
Q3 | $342K | Sell |
|
|||||
|
2023
Q2 | $445K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $301K | Sell |
|
|||||
|
2022
Q1 | $490K | Sell |
|
|||||
|
2021
Q4 | $1.18M | Sell |
|
|||||
|
2021
Q3 | $1.63M | Sell |
|
|||||
|
2021
Q2 | $1.75M | Sell |
|
|||||
|
2021
Q1 | $2.09M | Sell |
|
|||||
|
2020
Q4 | $3.22M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $485K | Sell |
|
|||||
|
2016
Q2 | $335K | Sell |
|
|||||
|
2016
Q1 | $434K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $434K | Sell |
|
|||||
|
2015
Q1 | $445K | Sell |
|
|||||
|
2014
Q4 | $321K | Sell |
|
|||||
|
2014
Q3 | $428K | Sell |
|
|||||
|
2014
Q2 | $341K | Sell |
|
|||||
|
2014
Q1 | $992K | Buy |
|